Dr. The lab in Reddy remembers 0.75% sodium chloride injection, 1000 mg/100ml (10 mg/ml) single -batch Levetiracetam in a single capacity injection bag.
The recall began after discovering that the injection bag was incorrectly labeled as a levetiracetam at 500 mg/100 ml of sodium chloride. However, the excess packaging correctly identifies the product from 0.75% sodium chloride infusion from 1000 mg/100ml to levetiracetam.
Levetiracetam in the vein is represented by adults (16 years old or older) that cannot be administered temporarily, with partial seizures, myopia seizures (youth myopia epilepsy patients) and primary generalized reinforced seizures temporarily. Patients who receive the affected product are more likely to doubles the dose of IV Revedirasetam rather than intended. This can cause serious side effects, including hypersensitivity, liver damage and hematological toxicity. People who are treated with IV Levetiracetam Epilepsy It can be at the greatest danger.
The influenced products include Lot# A1540076 and were distributed between November 4, 2024 and November 6, 2024. In particular, the bags and boxes that are recalled include:
- Products and deadlock status description: 0.75% sodium chloride injection 1000 mg/100 ml of levetiracetam; Product injection bag primary description: 0.82% sodium chloride injection 500 mg/100ml single capacity of Rebecirasetam; NDC# 43598-635-52; The expiration date of 8/2026.
- Products and deadlock status description: 0.75% sodium chloride injection 1000 mg/100 ml of levetiracetam; Product injection bag primary description: 0.75% sodium chloride injection 1000 mg/100ml single capacity of Rebecirasetam; NDC# 43598-636-52; The expiration date of 8/2026.
- Katon Description: 0.75% Levishirasetam at 1000 mg/100 ml sodium chloride injection; Single capacity bag; NDC# 43598-636-10; The expiration date of 8/2026.
Currently, the company has not received a report on side effects related to this recall. Dr. REDDY calls for immediate quarantine, not immediately used by the people who own the product.
The question about the recall is Dr. It can be provided to Reddy’s Medical Information Call Center (1-888-375-3784). Side effects should be reported to the Food and Drug Administration. Medwatch program.
reference :
Dr. REDDY’s issuance recalls Levetiracetam at 1,000 mg/100 mL of 0.75% sodium chloride in the United States due to the incorrect cover of the injection bag. press release. Dr. REDDY’s laboratory. March 13, 2025. https://www.busInesswire.com/news/home/20250313917328/en/dr.-riddys-nationalwide ODIUM-Chloride-Injection-1000-MG100-ML-In-in-in-Due-to-Mislabeling-of-Mislabeling-of-Infusion-of-Infus-Infus.
